Search
Insmed Inc
INSMAdd to Watchlist
111.120USD
+2.530+2.33%
Close 10-02 16:00（ET）
24.09BMarket Cap
LossP/E TTM
Insmed Inc (INSM) Stock Price Target & Forecast
Analyst Rating
Based on 24 analysts giving stock ratings to Insmed Inc in the past month.
Buy
7 Strong Buy
17 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
197.884USD+71.14%
INSM Analyst Recommendation Trends
In the current month, INSM has received 17 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. INSM average Analyst price target in the last month is 197.884.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
7
7
7
7
7
7
7
7
17
16
15
13
12
13
11
11
0
0
0
0
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
24
23
22
20
20
21
19
19
INSM Analyst Rating for Peer Comparison
Updated: Oct 3, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
0
0
27
argenx SE
ARGX
10
13
3
0
0
26
Ionis Pharmaceuticals Inc
IONS
6
14
5
0
0
25
IQVIA Holdings Inc
IQV
7
12
6
0
0
25
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
Cytokinetics Inc
CYTK
4
16
2
0
0
22
CRISPR Therapeutics AG
CRSP
4
8
10
0
0
22
Revolution Medicines Inc
RVMD
8
13
1
0
0
22
Tempus AI Inc
TEM
5
6
7
1
1
20
Ascendis Pharma A/S
ASND
10
10
0
0
0
20
Financial Forecasting
Based on analysts' estimates, INSM EPS is projected to reach -0.376 in FY2026Q3, following reported EPS of -0.061 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-1.29
-0.96
-0.78
-0.38
-0.35
Actual
-1.54
-0.76
-0.06
--
--
Surprise
-19.05%
+20.88%
+92.23%
--
--
FAQs
What is Insmed Inc's expected revenue for the next quarter?
Insmed Inc's expected revenue is 504.25M.
What is Insmed Inc's price target?
Analysts forecast that Insmed Inc's price target is USD 197.88, with the highest forecast at USD 243.00 and the lowest forecast at USD 169.00.
How have Insmed IncINSM's recent earnings per share performed?
The market expectation was USD -0.06, while Insmed IncINSM's earnings per share (EPS) for the previous quarter was USD -0.76. EPS for the next quarter is expected at USD -0.38.
What is the analyst rating for Insmed Inc?
Based on the ratings of Insmed Inc's stock from 24 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.